Cargando…

Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma

We studied the correlation between epidermal growth factor receptor (EGFR) and the tumor stem cell markers CD44/CD24 in breast invasive ductal carcinoma (BIDC) and their relationship with prognosis. We analyzed the clinical data of 139 BIDC cases retrospectively, detecting EGFR, CD44, and CD24 expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Zhousan, Shao, Nan, Weng, Huiwen, Li, Wen, Zhang, Jiaxing, Zhang, Luanjing, Yang, Lily, Ye, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246130/ https://www.ncbi.nlm.nih.gov/pubmed/25429827 http://dx.doi.org/10.1007/s12032-014-0275-2

Ejemplares similares

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

CD44(+)/CD24(-) phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
por: Lin, Yan, et al.
Publicado: (2012)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Differential expression of HIF-1α in CD44(+)CD24(-/low )breast ductal carcinomas
por: Oliveira-Costa, João Paulo, et al.
Publicado: (2011)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

Dynamic regulation of CD24 and the invasive, CD44(pos)CD24(neg )phenotype in breast cancer cell lines
por: Meyer, Matthew J, et al.
Publicado: (2009)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Utility of CD44/CD24 in the Outcome and Prognosis of Oral Squamous Cell Carcinoma: A Systematic Review
por: Poothakulath Krishnan, Reshma, et al.
Publicado: (2023)

Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44(+)/CD24(−) and ALDH1(+)): Prognostic Implications in Invasive Breast Cancer()()
por: Riaz, Nazia, et al.
Publicado: (2018)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Increased invasion and tumorigenicity capacity of CD44(+)/CD24(-) breast cancer MCF7 cells in vitro and in nude mice
por: Yan, Wenxing, et al.
Publicado: (2013)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

Can CD44+/CD24- Tumor Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?
por: Wu, Hong, et al.
Publicado: (2011)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

CD44(+)/CD24(- )breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
por: Sheridan, Carol, et al.
Publicado: (2006)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44(high)/CD24(−) Subpopulation
por: Zhang, Chenjing, et al.
Publicado: (2018)

Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
por: Fillmore, Christine, et al.
Publicado: (2007)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
por: Sahlberg, Sara Häggblad, et al.
Publicado: (2014)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
por: Yong, Ching-Shya, et al.
Publicado: (2012)

CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
por: Soave, Danilo Figueiredo, et al.
Publicado: (2013)

Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
por: Magalhães, Geórgia Modé, et al.
Publicado: (2013)

High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma
por: Xu, Yi, et al.
Publicado: (2017)

Breast cancer stromal fibroblasts promote the generation of CD44(+)CD24(- )cells through SDF-1/CXCR4 interaction
por: Huang, Mingzhu, et al.
Publicado: (2010)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma
por: Gu, Jichun, et al.
Publicado: (2022)

CD44(+)CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
por: Hurt, E M, et al.
Publicado: (2008)

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020)

Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance
por: Zhang, Jin, et al.
Publicado: (2019)

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549
por: Roudi, Raheleh, et al.
Publicado: (2013)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
por: Perrone, Giuseppe, et al.
Publicado: (2012)

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells
por: Di Stefano, Chiara, et al.
Publicado: (2018)

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis
por: Sosulski, Amanda, et al.
Publicado: (2016)

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
por: Vega, Francisco M., et al.
Publicado: (2020)

Identification of CD24 as a marker for tumorigenesis of melanoma
por: Tang, Ming-Rui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7f893l3alnto05cil1io54gebd